CSChetan Chandulal Shah

Chetan Chandulal Shah

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Chetan Chandulal Shah has a total of 61 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Experience with new technology: Point-of-care magnetic resonance imaging in the neonatal intensive care unit

    by Olivia R. Keller, Ashmitha Arun, Avni Sanghvi, Prachi H. Telkar, Chetan Chandulal Shah

    Neuroimaging is a crucial component of the management of neonates in the neonatal intensive care unit (NICU). Previously, challenges associated with the transport of neonates to a traditional 1.5-3T magnetic resonance imaging (MRI) machine have led to a reliance on ultrasound in the NICU, despite its limitations. Bedside availability of the neonatal MRI system has provided solutions to some of these challenges by decreasing the time of transport, providing continuous monitoring of the neonate, and cable management for lines and leads without an external magnetic field. We present our initial experience with the point-of-care NICU MRI through a clinical case. The point-of-care MRI successfully identified intracranial abnormalities, demonstrating its effectiveness in the NICU.

  • Is exceeding estimated bladder capacity during voiding cystourethrograms harmful?

    by Robert M DeFlorio, Monica S Epelman, Kimberly Christnacht, Henry Zheng, Chetan C Shah

    Objectives: The purpose of this study was to compare the actual bladder capacity of children undergoing voiding cystourethrogram (VCUG) with existing formula-derived estimates and to describe any adverse effects of bladder overdistention during VCUG. Methods: This retrospective study involved review of 884 consecutive VCUG performed over 3 years. Cases with underlying conditions that could artificially increase bladder capacity, such as neurogenic bladders or vesicoureteral reflux, were excluded. Results: Included were 440 normal VCUG procedures. Bladder volumes exceeded the expected bladder capacity set by the American Academy of Pediatrics (AAP) and American College of Radiology in 284 VCUG (65%). Of 261 VCUG performed on children 14 years of age, 7 (50%) exceeded the bladder capacity. No adverse effects were found after the VCUG in the 32 VCUG (7.3%) requiring a contrast volume of more than 2 times the AAP estimates and in the 22 VCUG studies (5%) requiring a contrast volume of more than 3 times the AAP estimates. Conclusion: This study suggests that current guidelines often underestimate bladder capacity, and exceeding the expected bladder capacity appears to be reasonably safe without the occurrence of complications. Advances in knowledge: Current AAP guidelines often underestimate the capacity of the urinary bladder. Exceeding the expected bladder capacity appears to be reasonably safe.

  • Open Access

    Clinically Isolated Syndrome and Frontal Lobe Arteriovenous Malformation Presenting With Behavior Issues

    by Chetan C. Shah, Christopher J. Dudek, Erick N. Viorritto, John J. Sarandria

    Prevalence of brain arteriovenous malformation ranges from 0.14% to 0.6% according to various estimates. A large number of these patients remain asymptomatic. The most common presentation is due to brain hemorrhage. A 14-year-old girl presented to the pediatrician with erratic behavior issues and hallucinations. She was diagnosed by the pediatrician and mental health facility as having schizophrenia and bipolar disorder. Once she was transferred to our children’s hospital, evaluation by a pediatric neurologist, computed tomography scan, magnetic resonance imaging, and laboratory workup including lumbar puncture confirmed a clinically isolated syndrome and frontal lobe arteriovenous malformation. Frontal lobe lesions including arteriovenous malformation in the frontal lobe can cause psychological symptoms and behavioral issues. We also discuss the differential diagnosis of acute demyelinating syndromes. J Med Cases. 2023;14(1):1-6 doi: https://doi.org/10.14740/jmc4005

  • Open Access

    Utility of Gadolinium Use in the Imaging Follow-Up of Nonenhancing Primary Brain Neoplasms in Children

    by Tiagpaul Bhamber, Zereen Sarwar, Yekaterina Jones, Brittany K. Albers, Chetan Shah

    Gadolinium-based contrast agents (GBCAs) have been administered clinically since 1988. They are remarkably well tolerated by children and result in dose-dependent tissue deposition, even in patients with normal renal function. No adverse effects of gadolinium deposition in patients with normal renal function have been established. Given the uncertain effects of gadolinium deposition, we sought to analyze gadolinium use in the imaging follow-up of nonenhancing primary brain neoplasms in children. This retrospective, institutional review board-approved and Health Insurance Portability and Accountability Act-compliant study evaluated pediatric patients who received GBCA in the routine evaluation of brain neoplasms. This special subset included 30 patients (<18 years old) with initially nonenhancing primary intracranial neoplasms who received treatment and follow-up at our institution. Patient data included sex, age from diagnosis to most recent imaging follow-up, number of contrast-enhanced magnetic resonance imaging (MRI) follow-up exams, and histopathology from a biopsy or resection. The group had an expected variety of tumors, including low-grade astrocytomas, dysembryoplastic neuroepithelial tumors, oligodendrogliomas, and teratomas. Half of our patients had tumors of unknown histopathology that were not biopsied or resected. The median age at diagnosis was 8.9 years, the median of four follow-up MRIs per patient, and the median follow-up time of four years. Only one of the 30 patients developed an enhancing focus on follow-up MRI that remained stable and asymptomatic over two years and did not require surgical intervention. Judicious use of GBCA in children, especially when numerous exams over many years are anticipated, is advised given the data regarding soft-tissue deposition. Preliminary results suggest that it may be feasible to omit GBCA from routine follow-ups of initially nonenhancing brain neoplasms.

  • Open Access

    Neuroimaging in Tick Paralysis: Looking Outside the Box

    by Zereen Sarwar, Aaron Fletcher Osborne, Chetan Shah, Mobeen H. Rathore

    Tick paralysis is a rare but potentially deadly form of muscle paralysis caused by a neurotoxin transmitted through the saliva of gravid, engorged female ticks of various species. Often, there is an initial misdiagnosis or delay in diagnosis due to the rarity of the diagnosis, the obscure location of the tick, and the disease’s clinical similarity to Guillain–Barre syndrome. We report the case of a 4-year-old girl with tick paralysis in whom the tick was not found until 2 days after hospital admission. Upon the review of the imaging, it was discovered that the tick was visible on the MRI of the brain that had been reported as normal.


  • Open Access

    Chiari III Malformation on Prenatal and Postnatal Imaging Complicated by Syndrome of Inappropriate Secretion of Anti-diuretic Hormone (SIADH) and Serratia marcescens Meningitis

    by Ryan McGeary, Chetan Shah

    Among various types of Chiari malformations (CMs), CM III is the most infrequently encountered. In this article, we present a case of CM III with occipital cephalocele appreciated on both prenatal imaging and postnatal follow-up MRI. This case illustrates not only the evolution of this malformation from the in-utero images of fetal MRI to the newborn MRI but also highlights the complications that may accompany this diagnosis such as hydrocephalus and infection. The patient also developed syndrome of inappropriate secretion of anti-diuretic hormone (SIADH). The most current thoughts on the pathophysiology of this entity are also reviewed along with an approach to the differential diagnosis and treatment.


  • Open Access

    Parietal Encephalocele With Fenestrated Superior Sagittal Sinus and Persistent Falcine Sinus

    by Yekaterina Kokidko, Nathan Ranalli, Chetan Shah

    We present a case of a newborn with a fenestrated superior sagittal sinus and persistent falcine sinus with a parietal encephalocele. The patient was born full-term without any associated pregnancy complications other than meconium-stained amniotic fluid at delivery. Following delivery, MRI brain demonstrated midline parietal encephalocele, persistent falcine sinus, fenestration of the superior sagittal sinus at the level of the encephalocele, subependymal heterotopia, and thick tectum. The patient underwent resection and repair on day 2 of life. MRI performed at 15 weeks of life showed a mild increase in the size of lateral ventricles. The patient did not require a ventriculoperitoneal shunt. This is a novel case that provides a valuable contribution to the existing body of literature about congenital encephalocele associated with persistent falcine sinus, fenestrated superior sagittal sinus, subependymal heterotopia, and thick tectum.


  • Open Access

    Safety and diagnostic efficacy of gadoteridol for magnetic resonance imaging of the brain and spine in children 2 years of age and younger

    by Chetan C. Shah, Maria Vittoria Spampinato, Hemant A. Parmar, Osama A. Raslan, Paolo Tomà, Doris D. M. Lin, Josef Vymazal, Cesare Colosimo, David S. Enterline

    Background: Neonates and young children require efficacious magnetic resonance imaging (MRI) examinations but are potentially more susceptible to the short- and long-term adverse effects of gadolinium-based contrast agents due to the immaturity of their body functions. Objective: To evaluate the acute safety and diagnostic efficacy of gadoteridol (ProHance) for contrast-enhanced MRI of the central nervous system (CNS) in children ≤2 years of age. Materials and methods: One hundred twenty-five children ≤2 years old (including 57 children P≤0.006 and 67.5–79.5% vs. 47.0–66.7%; P≤0.011, respectively). Conclusion: Gadoteridol at 0.1 mmol/kg body weight is safe, well tolerated and effective for contrast-enhanced MRI of the CNS in children ≤2 years of age.